New ultrasound trick could spare women unnecessary breast biopsies
NCT ID NCT07465523
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new way to use Doppler ultrasound to better tell the difference between benign (non-cancerous) and malignant (cancerous) breast lumps. Researchers will measure blood flow resistance in the lump and compare it to healthy breast tissue. If the method works, it could help doctors decide which lumps need a biopsy and which do not. The study involves 90 women with solid breast masses who already have pathology results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a non-invasive way to more accurately distinguish between benign and malignant breast lumps, potentially reducing the need for biopsies.
- What could go wrong
- This is a small, early-stage study with only 90 participants. The method may not prove reliable enough for widespread use, and results may not apply to all breast mass types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN BREAST NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karamanoğlu Mehmetbey University, KEAH
RECRUITINGKaraman, Lütfen Seçiniz., 70200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Triple attack on tough breast cancer: combining targeted therapies may improve outcomes
- Could an alcoholism drug plus copper fight breast cancer?
- Leg vein problems may slow recovery after knee surgery
- Breath test could spot breast cancer without needles or scans
- Mind over tumor: short therapy may improve chemo response in breast cancer
- New drug cocktail aims to delay chemo in metastatic breast cancer